Your browser doesn't support javascript.
loading
Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.
Luque-Ramírez, M; Nattero-Chávez, L; Rodríguez-Rubio Corona, C; Ortiz-Flores, A E; García-Cano, A M; Rosillo Coronado, M; Pérez Mies, B; Ruz Caracuel, I; Escobar-Morreale, H F.
Afiliación
  • Luque-Ramírez M; Diabetes, Obesity, and Human Reproduction Research Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) & Universidad de Alcalá, Centro de Investigación Biomédica en RED (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. manuel.luquer@uah.es.
  • Nattero-Chávez L; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, KM 9.1, 28034, Madrid, Spain. manuel.luquer@uah.es.
  • Rodríguez-Rubio Corona C; Diabetes, Obesity, and Human Reproduction Research Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) & Universidad de Alcalá, Centro de Investigación Biomédica en RED (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Ortiz-Flores AE; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, KM 9.1, 28034, Madrid, Spain.
  • García-Cano AM; Department of Gynecology and Obstetrics, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Rosillo Coronado M; Diabetes, Obesity, and Human Reproduction Research Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) & Universidad de Alcalá, Centro de Investigación Biomédica en RED (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Pérez Mies B; Department of Internal Medicine, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.
  • Ruz Caracuel I; Department of Biochemistry, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Escobar-Morreale HF; Department of Biochemistry, Hospital Universitario Ramón y Cajal, Madrid, Spain.
J Endocrinol Invest ; 47(8): 2007-2020, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38349517
ABSTRACT

PURPOSE:

Postmenopausal hyperandrogenism is a rare condition that requires identifying those women bearing a life-threatening tumor. We aimed to study diagnostic work-up and management of postmenopausal androgen excess, proposing an algorithm for clinical decision supporting.

METHODS:

We conducted an observational cross-sectional study and longitudinal follow-up including 51 consecutive menopausal patients reported for hyperandrogenism between 2003 and 2023 to our clinics. We assessed diagnostic testing accuracy and performance by receiver operating characteristic curves, their respective areas under the curve (AUCROC), and 95% confidence intervals (95%CI), for distinguishing between benign and malignant conditions, and androgen excess source.

RESULTS:

Most commonly, postmenopausal hyperandrogenism derived from benign conditions such as ovarian hyperthecosis (n = 9). However, four (8%) patients had borderline/malignant tumors arising at the ovaries (n = 3) or adrenals (n = 1). These latter were more likely to develop virilization than those with benign disorders [specificity(95%CI)] 0.87 (0.69; 0.92)]. Circulating total testosterone [AUCROC(95%CI) 0.899 (0.795; 1.000)] and estradiol [AUCROC(95%CI) 0.912 (0.812; 1.000)] concentrations showed good performances for discriminating between both conditions. Transvaginal-ultrasonography found two out of three potentially malignant ovarian neoplasms, and another was apparent on a pelvic computed tomography scan. An adrenal computed tomography scan also located an androgen-secreting carcinoma.

CONCLUSIONS:

Clinical or biochemical features of an aggressive androgen-secreting tumor should lead to urgently obtaining a targeted imaging. At first, an abdominal-pelvic CT scan represents the best choice to perceive adrenal malignancy, and may identify aggressive ovarian tumors. When warning signs are lacking, a calm and orderly work-up allows properly addressing the diagnostic challenge of postmenopausal hyperandrogenism.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Posmenopausia / Hiperandrogenismo / Andrógenos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: J Endocrinol Invest Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Posmenopausia / Hiperandrogenismo / Andrógenos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: J Endocrinol Invest Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia